Experienced in Hepatitis D

Dr. Obaid Shaikh

Hepatology
UPMC
University Of Pittsburgh Physicians
300 Halket St, 
Pittsburgh, PA 
Offers Telehealth
47 Years of Experience
Experienced in Hepatitis D
UPMC
University Of Pittsburgh Physicians
300 Halket St, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical Research

Overview

Obaid Shaikh is a Hepatologist in Pittsburgh, Pennsylvania. Dr. Shaikh has been practicing medicine for over 47 years and is rated as an Experienced provider by MediFind in the treatment of Hepatitis D. His top areas of expertise are Hepatitis, Hepatitis C, Cirrhosis, Alcoholic Cirrhosis, and Liver Transplant.

His clinical research consists of co-authoring 51 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hepatitis D.

Graduate Year
1979
Specialties
Hepatology
Licenses
Specialist in PA
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Penn Highlands Dubois
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Dominion National
  • MEDICARE PDP
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

UNIVERSITY OF PITTSBURGH PHYSICIANS
300 Halket St, Pittsburgh, PA 15213
Call: 814-371-0600
Other Locations
DUBOIS REGIONAL MEDICAL CENTER
621 S Main St, Penn Highlands Gastroenter, Du Bois, PA 15801
Call: 814-371-0600
DUBOIS REGIONAL MEDICAL CENTER
100 Hospital Ave, Du Bois, PA 15801

Additional Areas of Focus

Dr. Shaikh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma
Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma
Enrollment Status: Terminated
Publish Date: November 30, 2021
Intervention Type: Procedure, Device
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

51 Total Publications

Hepatocellular Carcinoma Among Patients With Metabolic Dysfunction Associated Steatotic Liver Disease.
Hepatocellular Carcinoma Among Patients With Metabolic Dysfunction Associated Steatotic Liver Disease.
Journal: Gastro hep advances
Published: November 20, 2024
View All 51 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shaikh's expertise for a condition
ConditionClose
    • Distinguished
    • Hepatitis
      Dr. Shaikh is
      Distinguished
      . Learn about Hepatitis.
      See more Hepatitis experts
    • Hepatitis C
      Dr. Shaikh is
      Distinguished
      . Learn about Hepatitis C.
      See more Hepatitis C experts
    • Advanced
    • Alcoholic Cirrhosis
      Dr. Shaikh is
      Advanced
      . Learn about Alcoholic Cirrhosis.
      See more Alcoholic Cirrhosis experts
    • Autoimmune Hepatitis
      Dr. Shaikh is
      Advanced
      . Learn about Autoimmune Hepatitis.
      See more Autoimmune Hepatitis experts
    • Cirrhosis
      Dr. Shaikh is
      Advanced
      . Learn about Cirrhosis.
      See more Cirrhosis experts
    • Enlarged Liver
      Dr. Shaikh is
      Advanced
      . Learn about Enlarged Liver.
      See more Enlarged Liver experts
    • Primary Biliary Cholangitis
      Dr. Shaikh is
      Advanced
      . Learn about Primary Biliary Cholangitis.
      See more Primary Biliary Cholangitis experts
    • Reynolds Syndrome
      Dr. Shaikh is
      Advanced
      . Learn about Reynolds Syndrome.
      See more Reynolds Syndrome experts
    View All 7 Advanced Conditions
    • Experienced
    • Ascites
      Dr. Shaikh is
      Experienced
      . Learn about Ascites.
      See more Ascites experts
    • Banti's Syndrome
      Dr. Shaikh is
      Experienced
      . Learn about Banti's Syndrome.
      See more Banti's Syndrome experts
    • Budd-Chiari Syndrome
      Dr. Shaikh is
      Experienced
      . Learn about Budd-Chiari Syndrome.
      See more Budd-Chiari Syndrome experts
    • Cholangitis
      Dr. Shaikh is
      Experienced
      . Learn about Cholangitis.
      See more Cholangitis experts
    • Esophageal Varices
      Dr. Shaikh is
      Experienced
      . Learn about Esophageal Varices.
      See more Esophageal Varices experts
    • Hepatitis B
      Dr. Shaikh is
      Experienced
      . Learn about Hepatitis B.
      See more Hepatitis B experts
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.